Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Heme biosynthesis].

U A Meyer

    Schweizerische Medizinische Wochenschrift
    |September 13, 1975
    PubMed
    Summary
    This summary is machine-generated.

    The body synthesizes 300-400 mg of heme daily, essential for hemoglobin and cytochromes. Key regulatory events focus on delta-aminolevulinic acid synthetase, the initial enzyme in heme formation.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

    Clinical pharmacology and therapeutics·2015
    Same author

    Personalized medicine: a personal view.

    Clinical pharmacology and therapeutics·2012
    Same author

    Hypolipidemic effects of silymarin are not mediated by the peroxisome proliferator-activated receptor alpha.

    Xenobiotica; the fate of foreign compounds in biological systems·2007
    Same author

    Multiple enhancer units mediate drug induction of CYP2H1 by xenobiotic-sensing orphan nuclear receptor chicken xenobiotic receptor.

    Molecular pharmacology·2001
    Same author

    Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans.

    Molecular endocrinology (Baltimore, Md.)·2001
    Same author

    Identification and functional characterization of eight CYP3A4 protein variants.

    Pharmacogenetics·2001
    Same journal

    Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Boeck's disease as a tuberculous syndrome.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Enteral primary tubercular complexes

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Tuberculous stenoses of the large bronchi.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    About the enzyme action.

    Schweizerische medizinische Wochenschrift·2010
    See all related articles

    Area of Science:

    • Biochemistry
    • Cellular Biology

    Context:

    • Heme is a critical prosthetic group for hemoproteins like hemoglobin and cytochromes.
    • Heme synthesis occurs primarily in the bone marrow and liver.
    • The multi-step heme biosynthesis pathway involves at least seven enzymes and several intermediate products.

    Purpose:

    • To outline the fundamental aspects of heme synthesis.
    • To identify the key regulatory enzyme in heme production.

    Summary:

    • Daily heme synthesis in the organism ranges from 300 to 400 mg.
    • The pathway converts glycine and succinyl coenzyme A into heme through a series of enzymatic reactions.
    • Delta-aminolevulinic acid synthetase is the rate-limiting enzyme and a major point of regulation for heme formation.

    Impact:

    • Understanding heme synthesis is crucial for comprehending various physiological processes.
    • Identifying regulatory points like delta-aminolevulinic acid synthetase can inform therapeutic strategies for heme-related disorders.